1.Mechanism of pirfenidone inhibiting cell pyroptosis and reduceing myocardial fibrosis
Zifeng HE ; Xiangwei LÜ ; Yang QIN ; Weikun ZHAO ; Liqin CHEN ; Yuechang LI ; Yufen LU
Chinese Journal of Geriatric Heart Brain and Vessel Diseases 2025;27(1):94-99
Objective To observe the effect of pirfenidone on myocardial fibrosis in rats and inves-tigate its underlying mechanism.Methods Twenty-four SD rats were randomly divided into sham-operation group,model group,low-and high-dose pirfenidone groups,with 6 rats in each group.Rat model of myocardial fibrosis was established by injecting isoprenaline into the tail vein,while normal saline was given to the sham operation group.Pirfenidone of 150 and 300 mg/(kg·d)were infused gastrically to the rats of low-and high-dose pirfenidone groups after modeling.Mas-son staining was used to observe the severity of myocardial fibrosis,immunohistochemical assay was employed to detect the expression of Collagen-1,NOD-like receptor thermal protein domain associated protein 3(NLRP3)inflammasome,cysteinyl aspartate-specific protease-1(Caspase-1),and Western blotting was performed to detect the protein levels of Collogen-1 and atrial desmo-plakin D(gasdermin D,GSDMD).Results The model group showed obvious myocardial fibrosis,and elevated expression of Collogen-1,NLRP3,Caspase-1 and GSDMD when compared with the sham operation group(P<0.05).Low-and high-dose pirfenidone treatment resulted in signifi-cantly reduced myocardial fibrosis and reduced expression of Collogen-1,NLRP3,Caspase-1 and GSDMD[(8.14±1.40)%,(6.56±0.75)%vs(22.15±2.57)%,P<0.05;0.14±0.03 vs 0.33±0.05,0.42±0.13,P<0.05;(10.34±1.40)%,(10.33±3.40)%vs(23.22±1.99)%,P<0.05;(15.67±0.56)%,(17.33±0.78)%vs(22.87±1.92)%,P<0.05;0.43±0.06,0.46±0.11 vs 0.65±0.03,P<0.05].Conclusion Pirfenidone inhibits cardiomyocyte pyroptosis and attenuates myocar-dial fibrosis through the NLRP3/Caspase-1/GSDMD signaling axis.
2.Mechanism of pirfenidone inhibiting cell pyroptosis and reduceing myocardial fibrosis
Zifeng HE ; Xiangwei LÜ ; Yang QIN ; Weikun ZHAO ; Liqin CHEN ; Yuechang LI ; Yufen LU
Chinese Journal of Geriatric Heart Brain and Vessel Diseases 2025;27(1):94-99
Objective To observe the effect of pirfenidone on myocardial fibrosis in rats and inves-tigate its underlying mechanism.Methods Twenty-four SD rats were randomly divided into sham-operation group,model group,low-and high-dose pirfenidone groups,with 6 rats in each group.Rat model of myocardial fibrosis was established by injecting isoprenaline into the tail vein,while normal saline was given to the sham operation group.Pirfenidone of 150 and 300 mg/(kg·d)were infused gastrically to the rats of low-and high-dose pirfenidone groups after modeling.Mas-son staining was used to observe the severity of myocardial fibrosis,immunohistochemical assay was employed to detect the expression of Collagen-1,NOD-like receptor thermal protein domain associated protein 3(NLRP3)inflammasome,cysteinyl aspartate-specific protease-1(Caspase-1),and Western blotting was performed to detect the protein levels of Collogen-1 and atrial desmo-plakin D(gasdermin D,GSDMD).Results The model group showed obvious myocardial fibrosis,and elevated expression of Collogen-1,NLRP3,Caspase-1 and GSDMD when compared with the sham operation group(P<0.05).Low-and high-dose pirfenidone treatment resulted in signifi-cantly reduced myocardial fibrosis and reduced expression of Collogen-1,NLRP3,Caspase-1 and GSDMD[(8.14±1.40)%,(6.56±0.75)%vs(22.15±2.57)%,P<0.05;0.14±0.03 vs 0.33±0.05,0.42±0.13,P<0.05;(10.34±1.40)%,(10.33±3.40)%vs(23.22±1.99)%,P<0.05;(15.67±0.56)%,(17.33±0.78)%vs(22.87±1.92)%,P<0.05;0.43±0.06,0.46±0.11 vs 0.65±0.03,P<0.05].Conclusion Pirfenidone inhibits cardiomyocyte pyroptosis and attenuates myocar-dial fibrosis through the NLRP3/Caspase-1/GSDMD signaling axis.
3.Mechanism of miR-483-3p regulating autophagy to reduce myocardial fibrosis in rats
Liqin CHEN ; Xiangwei LÜ ; Weikun ZHAO ; Qiuyu QIN ; Zifeng HE ; Yuechang LI ; Yufen LU
Chinese Journal of Geriatric Heart Brain and Vessel Diseases 2024;26(6):683-687
Objective To study the role of microRNA(miR)-483-3p in reducing myocardial fibrosis in rats,and explore the relationship between its mechanism and autophagy.Methods A total of 24 male SD rats were randomly divided into sham operation group,model group,blank transfec-tion group and high expression group,with 6 rats in each group.The blank transfection group and the high-expression group were pretreated with a single injection of adeno-associated virus(AAV)-blank transfection and AAV-miR-483-3p(5×1011 vg)in the tail vein,respectively.In 14 d later,the sham group was injected with 2.5 ml/(kg·d)normal saline for 14 d,and rat model of myocardial fibrosis was established by 2 mg/ml isoproterenol[2.5 ml/(kg·d)]injection through tail vein for 14 consecutive days.Myocardial pathological damage,severity of myocardial fibrosis,and expression levels of collagen-Ⅰ,microtubule-associated protein light chain 3(LC3),autoph-agy-related protein 5(Atg5)and autophagy degradation substrate(P62)in cardiomyocytes were evaluated and measured.Results Compared with the sham operation group,the model group had obviously larger myocardial fibrosis area,higher positive expression of Collagen-Ⅰ,and increased protein levels of Atg5 and LC3-Ⅱ/LC3-Ⅰ,and decreased expression level of P62 protein(P<0.05).The myocardial fibrosis area,positive expression of Collagen-Ⅰ,the expression levels of Atg5 and LC3-Ⅱ/LC3-Ⅰ protein[(13.64±1.51)%vs(27.47±1.55)%,(13.48±3.07)%vs(30.91±2.45)%,0.98±0.17 vs 1.24±0.28,0.66±0.05 vs 1.26±0.09,P<0.05]were significant-ly decreased,and the expression level of P62 was notably increased(0.91±0.11 vs 0.74±0.06,P<0.05)in the high expression group than the model group.Conclusion MiR-483-3p attenuates myocardial fibrosis in rats,and the mechanism may be related to the inhibition of cardiomyocyte autophagy.
4.Analysis of factors related to vitamin D deficiency in hospitalized patients with type 2 diabetes mellitus
Yuqiong CHEN ; Yufen QIAN ; Xiaoqing HAN ; Tao LIN ; Qin WANG
Chinese Journal of Diabetes 2024;32(12):928-931
Objective To investigate the incidence and related factors of vitamin D deficiency(VDD) in hospitalized patients with type 2 diabetes mellitus (T2DM). Methods 2139 patients with T2DM who were hospitalized in The Endocrinology Department of Kunshan Hospital of Traditional Chinese Medicine from January 2018 to June 2023 were enrolled in the study. All the subjects were divided into VDD group (n=1301) and T2DM group (n=838),according to the international standard of vitamin D level. General data and biochemical indicators compared between the two groups. According to the interquartile interval of MHR value,it was divided into Q1(MHR≤0.272,n=534),Q2(0.272
5.Analysis of factors related to vitamin D deficiency in hospitalized patients with type 2 diabetes mellitus
Yuqiong CHEN ; Yufen QIAN ; Xiaoqing HAN ; Tao LIN ; Qin WANG
Chinese Journal of Diabetes 2024;32(12):928-931
Objective To investigate the incidence and related factors of vitamin D deficiency(VDD) in hospitalized patients with type 2 diabetes mellitus (T2DM). Methods 2139 patients with T2DM who were hospitalized in The Endocrinology Department of Kunshan Hospital of Traditional Chinese Medicine from January 2018 to June 2023 were enrolled in the study. All the subjects were divided into VDD group (n=1301) and T2DM group (n=838),according to the international standard of vitamin D level. General data and biochemical indicators compared between the two groups. According to the interquartile interval of MHR value,it was divided into Q1(MHR≤0.272,n=534),Q2(0.272
6. Experimental study of schisandrin B attenuates acute myocardial ischemia injury in rats by inhibiting cardiomyocyte apoptosis
Haiyan HUA ; Jie YAN ; Yufen QIN
Chinese Journal of Clinical Pharmacology and Therapeutics 2022;27(8):848-856
AIM: To explore the protective effect and mechanism of schisandrin B (Sch B) on myocardial ischemia-reperfusion injury (MIRI) in rats. METHODS: Forty SD rats were randomly divided into control group, MIRI group, MIRI +30 mg/kg Sch B (MIRI + L-Sch B) group and MIRI +60 mg/kg Sch B (MIRI + H-Sch B) group, ten in each group, Sch B were intragastrically for 7 days. Ligation of the left anterior descending branch was used to establish MIRI model, control group rats only underwent sham operation. The ardiac function parameters of ejection fraction (EF), fractional shortening (FS), maximum rate of increase in left ventricular pressure (+ dp/dt
7.Influence of dietary nutrition intervention on patients with psoriasis
Yufang ZHAO ; Guiling QIN ; Yufen LI
Chinese Journal of Practical Nursing 2014;30(11):16-18
Objective To study on the effect of dietary nutrition intervention in community on nutrition knowledge and dietary compliance in patients with psoriasis.Methods 40 patients with psoriasis were given a balanced diet pagoda and food exchange method,along with psoriasis nutrition knowledge manual to make individual and concise diet prescription.The nutrition knowledge and dietary compliance of patients before and after the intervention were compared.Results In a nutrition knowledge test,before the intervention,31 patients obtained a score below 60 which accounted for 77.5%,and 9 patients got higher score which meant 22.5% patients had a good dietary compliance.After the intervention,18 patients (45.0%) got a score below 60,while 22 (55.5%) patients got a good score,the results after the intervention were statistically higher than those before the intervention.Conclusions Patients with psoriasis have poor cognitions and bad dietary compliance.After dietary nutrition intervention,the nutrition knowledge is enhanced and the dietary compliance gets higher,the dietary structure is improved,and consequently accelerate the recovery of disease.
8.Transcatheter establishment of an animal model with acute aortic valve regurgitation:an experimental study
Xiang CHEN ; Feiyu WANG ; Hongwen TAN ; Yuan BAI ; Yufen ZHU ; Zhigang ZHANG ; Ben ZHANG ; Xianxian ZHAO ; Yongwen QIN ; Junbo GE
Journal of Interventional Radiology 2014;(7):615-618
Objective To explore the feasibility and effectiveness of interventional transcatheter destruction of the aortic valve to establish an animal model with acute aortic valve regurgitation. Methods Eight healthy goats were used for this study. A limited sternotomy approach was used to access the apex of the heart. Puncturing of the apex of the heart was performed to establish a wire track, then, under fluoroscopic guidance a 10 F sheath was inserted along this track of hard wire until to the ascending aorta above the aortic valve. The internal sheath was removed. Via the 10 F sheath a 10 mm occluder of ventricular septal defect (VSD) was introduced into the ascending aorta above the aortic valve. The sheath was pulled back to the left ventricle, while the occluder remained in the ascending aorta above the aortic valve. Then the occluder was quickly pulled back into the left ventricle in order to make some certain damage to the aortic valve. And an acute aortic valve regurgitation model was thus established. Angiography of ascending aorta above the aortic Among the 8 animals, two died of acute left ventricular failure on the spot due to excessive regurgitation blood flow after the operation. Macroscopically, damage of the aortic valve was seen. In the six survivors, angiography of ascending aorta above the aortic valve and Doppler echocardiography showed that moderate degree of regurgitation was detected in 5 and small amount of regurgitation in one. Two experimental goats with moderate degree of regurgitation died of heart failure separately at seven days and fifteen days after the operation. The remaining four experimental goats survived for more than three months. Follow- up checkups with echocardiography suggested the presence of mild- moderate degree of regurgitation. Conclusion Acute aortic valve regurgitation model in experimental goats can be established through transapical transcatheter damage of aortic valve by quickly pulling back a VSD occluder which has been placed in the ascending aorta above the aortic valve. This method is clinically feasible, technically simple and repeatable, the result is reliable, and the degree of regurgitation is controllable.
9.Polymorphisms of GSTM1,GSTT1 and susceptibility of laryngeal and hypopharyngeal carcinomas
Qin LI ; Lingrong WANG ; Yanlin CHEN ; Yinghua DU ; Ping KONG ; Yufen LI ; Xiaoqun XU
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2009;(24):1105-1107,1111
Objective:To study the relationship between genetic polymorphisms of GSTM1 GSTT1 and the susceptibility of laryngeal and hypopharyngeal carcinomas(LHC).Method:The GSTM1 an GSTT1 genotypes were determined by multiplex PCR analysis in 76 LHC patients and 76 population controls.The association be tween the genotypes and LHC risk was measured by odds ratios(ORs)and 95% confidence intervals(95%Cls).Resuit:The frequency of GSTM1 null genotype was 59.2% in the LHC patients and 42.1% in controls(OR=1.935,95%CI=1.069-3.510),the difference was significant(P<0.01).The frequency of GSTT1 null genotype was 57.9% in the LHC patients and 51.3% in controls.The difference was not significant(P>0.05).In smokers,the risk of the LHC increased in subjects of GSTM1 null genotype(OR=5.545,95%CI=2.158-13.528).Conclusion:GSTM1 polymorphisms are associated with susceptibility to the LHC.It has the synergistic effects with smoking in the development of the LHC.GSTT1 genotypes might have no association with risk of the LHC in urban Linyi.
10.Polymorphisms of GSTM1, GSTT1 and susceptibility of laryngeal and hypopharyngeal carcinomas.
Qin LI ; Lingrong WANG ; Yanlin CHEN ; Yinghua DU ; Ping KONG ; Yufen LI ; Xiaoqun XU
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2009;23(24):1105-1111
OBJECTIVE:
To study the relationship between genetic polymorphisms of GSTM1 GSTT1 and the susceptibility of laryngeal and hypopharyngeal carcinomas (LHC).
METHOD:
The GSTM1 and GSTT1 genotypes were determined by multiplex PCR analysis in 76 LHC patients and 76 population controls. The association between the genotypes and LHC risk was measured by odds ratios (ORs) and 95% confidence intervals (95% CIs).
RESULT:
The frequency of GSTM1 null genotype was 59.2% in the LHC patients and 42.1% in controls (OR=1.935, 95% CI=1.069-3.510), the difference was significant (P<0.01). The frequency of GSTT1 null genotype was 57.9% in the LHC patients and 51.3% in controls. The difference was not significant (P>0.05). In smokers, the risk of the LHC increased in subjects of GSTM1 null genotype (OR=5.545, 95% CI=2.158-13.528).
CONCLUSION
GSTM1 polymorphisms are associated with susceptibility to the LHC. It has the synergistic effects with smoking in the development of the LHC. GSTT1 genotypes might have no association with risk of the LHC in urban Linyi.
Carcinoma, Squamous Cell
;
genetics
;
Case-Control Studies
;
Disease Susceptibility
;
Female
;
Gene Frequency
;
Genotype
;
Glutathione Transferase
;
genetics
;
Humans
;
Hypopharyngeal Neoplasms
;
genetics
;
Laryngeal Neoplasms
;
genetics
;
Male
;
Polymorphism, Genetic

Result Analysis
Print
Save
E-mail